• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国疾病成本研究:对直接成本所用方法的系统评价

Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost.

作者信息

Clabaugh Gerd, Ward Marcia M

机构信息

Department of Health Management and Policy, University of Iowa, Iowa City, IA, USA.

出版信息

Value Health. 2008 Jan-Feb;11(1):13-21. doi: 10.1111/j.1524-4733.2007.00210.x.

DOI:10.1111/j.1524-4733.2007.00210.x
PMID:18237356
Abstract

OBJECTIVES

We undertake a systematic review to examine the methods used by researchers in developing cost-of-illness (COI) studies. This review aims to categorize the approaches that the published literature uses in terms of perspective, scope, components of care analyzed in the literature, data sets, and valuation approaches used for direct cost. It draws conclusions regarding the adequacy of current COI research methods and makes recommendations on improving them.

METHODS

The online bibliographic information service HealthSTAR (which incorporates MEDLINE) was used to search for COI studies in the research literature published during the period from 2000 to 2004. The search strategy used the term "cost of illness" as a MeSH (medical subject heading) term.

RESULTS

The HealthSTAR literature search identified references to 650 articles. Review of abstracts resulted in the identification of 170 of these for a more detailed review. This process identified 52 articles that met all criteria of COI studies. We identified 218 components of care analyzed across the 52 articles. Private-insurance or employer-claims data sets comprised the largest source of utilization and cost information among the studies.

CONCLUSION

Analyzing cost of illness presents useful opportunities for communicating with the public and policymakers on the relative importance of specific diseases and injuries. Our research, however, indicates that COI studies employ varied approaches and many articles have methodological limitations. Without well-accepted standards to guide researchers in their execution of these studies, policymakers and the general public must be wary of the methods used in their calculation and subsequent results.

摘要

目的

我们进行了一项系统综述,以考察研究人员在开展疾病成本(COI)研究时所使用的方法。本综述旨在根据视角、范围、文献中分析的护理组成部分、数据集以及用于直接成本的估值方法,对已发表文献中使用的方法进行分类。它得出了关于当前COI研究方法充分性的结论,并就改进这些方法提出了建议。

方法

利用在线书目信息服务HealthSTAR(其中包含MEDLINE),在2000年至2004年期间发表的研究文献中搜索COI研究。搜索策略使用“疾病成本”作为医学主题词(MeSH)。

结果

HealthSTAR文献搜索识别出650篇文章的参考文献。对摘要的审查导致从中确定了170篇进行更详细的审查。这一过程确定了52篇符合COI研究所有标准的文章。我们在这52篇文章中识别出218个分析的护理组成部分。在这些研究中,私人保险或雇主索赔数据集是使用和成本信息的最大来源。

结论

分析疾病成本为就特定疾病和伤害的相对重要性与公众和政策制定者进行沟通提供了有用的机会。然而,我们的研究表明,COI研究采用了多种方法,许多文章存在方法学上的局限性。由于缺乏被广泛接受的标准来指导研究人员开展这些研究,政策制定者和公众必须对计算中使用的方法及其后续结果保持警惕。

相似文献

1
Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost.美国疾病成本研究:对直接成本所用方法的系统评价
Value Health. 2008 Jan-Feb;11(1):13-21. doi: 10.1111/j.1524-4733.2007.00210.x.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
8
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
9
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
10
Direct composite resin fillings versus amalgam fillings for permanent posterior teeth.直接复合树脂充填与银汞合金充填用于永久性后牙。
Cochrane Database Syst Rev. 2021 Aug 13;8(8):CD005620. doi: 10.1002/14651858.CD005620.pub3.

引用本文的文献

1
Towards more reliable gambling cost estimates, a population-based study with register-linkage.为了获得更可靠的赌博成本估计,开展一项基于人群的登记联动研究。
BMC Public Health. 2025 Aug 19;25(1):2839. doi: 10.1186/s12889-025-24043-x.
2
Cost Analysis Related to Diagnosis, Treatment and Management of Cervical Cancer in Antigua and Barbuda: A Prevalence-Based Cost-of-Illness Study.安提瓜和巴布达宫颈癌诊断、治疗及管理相关成本分析:一项基于患病率的疾病成本研究
Int J Environ Res Public Health. 2024 Dec 18;21(12):1685. doi: 10.3390/ijerph21121685.
3
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review.
治疗银屑病关节炎的成本及成本效益:一项更新的系统文献回顾。
Pharmacoeconomics. 2024 Dec;42(12):1329-1343. doi: 10.1007/s40273-024-01428-1. Epub 2024 Aug 24.
4
Cost of illness of breast cancer in low- and middle-income countries: a systematic review.低收入和中等收入国家乳腺癌的疾病成本:一项系统综述
Health Econ Rev. 2024 Jul 22;14(1):56. doi: 10.1186/s13561-024-00536-0.
5
Economic impact of informal caring for a person with arthritis in Australia from 2015 to 2030: a microsimulation approach using national survey data.2015 年至 2030 年澳大利亚关节炎患者非正规护理的经济影响:基于全国调查数据的微观模拟方法
BMJ Open. 2024 May 5;14(5):e076966. doi: 10.1136/bmjopen-2023-076966.
6
Healthcare Costs at the End of Life for Patients with Non-cancer Diseases and Cancer in Denmark.丹麦非癌症疾病和癌症患者临终时的医疗费用。
Pharmacoecon Open. 2023 Sep;7(5):751-764. doi: 10.1007/s41669-023-00430-1. Epub 2023 Aug 8.
7
Expert opinion on a consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies: qualitative interviews.基于共识的成本效益研究(COI)评估清单的专家意见:定性访谈。
Int J Technol Assess Health Care. 2023 Jun 9;39(1):e33. doi: 10.1017/S0266462323000181.
8
The price of neonatal intensive care outcomes - in-hospital costs of morbidities related to preterm birth.新生儿重症监护结果的代价——与早产相关疾病的住院费用。
Front Pediatr. 2023 Feb 7;11:1068367. doi: 10.3389/fped.2023.1068367. eCollection 2023.
9
The Economic Burden of Acute Myeloid Leukemia in Iran.伊朗急性髓系白血病的经济负担
Iran J Public Health. 2022 Nov;51(11):2599-2607. doi: 10.18502/ijph.v51i11.11178.
10
Cost of illness in a super-aged society-comparison of breast, lung, and prostate cancer in Japan.在超老龄社会中的疾病负担——以日本的乳腺癌、肺癌和前列腺癌为例。
BMC Geriatr. 2022 Dec 14;22(1):964. doi: 10.1186/s12877-022-03683-3.